
The new centre will be home to nearly 2,000 world-class researchers and scientists

An estimated two million people in the UK are living with undiagnosed chronic obstructive pulmonary disease

This builds on a recently announced clinical collaboration between AstraZeneca and Summit to advance cancer treatments

Around 33,000 people in the UK are currently living with multiple myeloma, an incurable type of blood cancer

The results from a global phase 3 trial show the longest survival data ever reported in this setting

This is the first new regimen in more than a decade for first-line treatment for this type of breast cancer

Excessive sweating affects 1-5% of the population and can have a substantial impact on quality of life

The treatments are for eligible adults in England and Wales

A record two million women were prescribed hormone replacement therapy in 2025/26 compared to 0.8 million in 2020/21

Asthma affects over 360 million people worldwide, including over 40 million people in Europe

The company will gain a novel oral treatment for lung cancer

It is estimated that 3,300 women are diagnosed with cervical cancer in the UK each year